Results 11 to 20 of about 62,795 (319)
Polycythemia vera: 2024 update on diagnosis, risk‐stratification, and management
American journal of hematology/oncology, 2023 Polycythemia vera (PV) is a JAK2‐mutated myeloproliferative neoplasm characterized by clonal erythrocytosis; other features include leukocytosis, thrombocytosis, splenomegaly, pruritus, constitutional symptoms, microcirculatory disturbances, and ...
A. Tefferi, T. Barbui
semanticscholar +1 more source
JAK2V617F allele burden in polycythemia vera: burden of proof
Blood, 2023 Visual ...
A. Moliterno, H. Kaizer, B. Reeves
semanticscholar +1 more source
Ropeginterferon versus Standard Therapy for Low-Risk Patients with Polycythemia Vera.
NEJM Evidence, 2023 Ropeginterferon for Patients with Polycythemia VeraPatients with low-risk polycythemia vera were randomly assigned to receive ropeginterferon alfa-2b and phlebotomy or phlebotomy alone.
T. Barbui +37 more
semanticscholar +1 more source
Polycythemia vera: historical oversights, diagnostic details, and therapeutic views
Leukemia, 2021 Polycythemia vera (PV) is a relatively indolent myeloid neoplasm with median survival that exceeds 35 years in young patients, but its natural history might be interrupted by thrombotic, fibrotic, or leukemic events, with respective 20-year rates of 26%,
A. Tefferi, A. Vannucchi, T. Barbui
semanticscholar +1 more source
Journal of Hematology & Oncology, 2021 In a population of 42 Philadelphia negative myeloproliferative neoplasm patients, all on systemic active treatment, the likelihood of responding to anti-SARS-CoV-2 BNT162b2 vaccine at 2 weeks after the second dose was significantly lower in the ten ...
F. Pimpinelli +18 more
semanticscholar +1 more source
Polycythemia in chronic obstructive pulmonary disease in Minia Cardiothoracic University Hospital
Egyptian Journal of Chest Disease and Tuberculosis, 2023 Background Secondary polycythemia is linked to cigarette smoking and chronic obstructive pulmonary disease (COPD). However, the prevalence of polycythemia and its possible risk factors in patients with COPD have not been widely studied.
Rasha A Abdelfattah +4 more
doaj +1 more source
Utility of Hounsfield Unit: Haematocrit Ratio in Diagnosing Acute Cerebral Venous Sinus Thrombosis on Unenhanced Computed Tomography [PDF]
International Journal of Anatomy Radiology and Surgery, 2021 Introduction: The non-invasive imaging technique of choice in diagnosing Cerebral Venous Sinus Thrombosis (CVST) is Magnetic Resonance Imaging (MRI), but it has its own set of limitations like not being available universally in the acute setting ...
NARASIPURA LINGAIAH RAJENDRA KUMAR +3 more
doaj +1 more source
American journal of hematology/oncology, 2020 Polycythemia vera (PV) and essential thrombocythemia (ET) are myeloproliferative neoplasms (MPN) respectively characterized by clonal erythrocytosis and thrombocytosis; other disease features include leukocytosis, splenomegaly, thrombosis, bleeding ...
A. Tefferi, T. Barbui
semanticscholar +1 more source
Interstitial lung disease with congenital erythrocytosis
Journal of Clinical and Scientific Research, 2022 A 45-year-old male weaver, smoker, known case of interstitial lung disease with cor pulmonale on long-term oxygen therapy diagnosed 6 months ago who is on tapering doses of oral steroids presented to our tertiary care teaching hospital with complaints of
D T Katyarmal +5 more
doaj +1 more source
Single fetal demise in twin anemia-polycythemia sequence: perinatal outcome of surviving cotwin. [PDF]
Ultrasound Obstet GynecolABSTRACT Objective To evaluate the perinatal outcome after spontaneous single intrauterine fetal demise (IUFD) in monochorionic twin pregnancies with twin anemia–polycythemia sequence (TAPS). Methods This was a retrospective study of all monochorionic twin pregnancies with TAPS that underwent spontaneous single IUFD and were registered in the ...
van de Sande MJA +12 more
europepmc +2 more sources